Skip header and navigation
Did you mean causation?

Narrow By

40 records – page 1 of 2.

About Nova Scotia Health’s smoke and tobacco reduction policy

https://libcat.nshealth.ca/en/permalink/chpams36768
Nova Scotia Health Authority. Mental Health and Addictions, Nova Scotia Health Authority. Respiratory Therapy Services, Nova Scotia Health Authority. Occupational Health Safety and Wellness. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1547
Available Online
View Pamphlet
Nova Scotia Health promotes a smoke-free, tobacco-free, and vape-free environment for patients, visitors, and staff. Nova Scotia Health is committed to helping people smoke less, stop smoking, and stay smoke-free. This pamphlet provides information about smudging ceremonies, stopping smoking, referral to Tobacco Free Nova Scotia (TFNS), and what to do if you decide you are ready to try to quit tobacco. Contact information for TFNS and the Stop Smoking Program is provided. The French version of …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Mental Health and Addictions
Nova Scotia Health Authority. Respiratory Therapy Services
Nova Scotia Health Authority. Occupational Health Safety and Wellness
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Smoking Cessation
Tobacco Use Cessation Devices
Subjects (LCSH)
Smoking cessation
Smoking cessation products
Specialty
Hospitals
Abstract
Nova Scotia Health promotes a smoke-free, tobacco-free, and vape-free environment for patients, visitors, and staff. Nova Scotia Health is committed to helping people smoke less, stop smoking, and stay smoke-free. This pamphlet provides information about smudging ceremonies, stopping smoking, referral to Tobacco Free Nova Scotia (TFNS), and what to do if you decide you are ready to try to quit tobacco. Contact information for TFNS and the Stop Smoking Program is provided. The French version of this pamphlet 1548, "Politique de réduction du tabagisme de Santé Nouvelle-Écosse," is also available.
Responsibility
Prepared by: Mental Health & Addictions, Respiratory Therapy, Occupational Health Safety & Wellness
Pamphlet Number
1547
Less detail

Advances in Cancer Survivorship Management

https://libcat.nshealth.ca/en/permalink/provcat38935
Lewis E. Foxhall, Maria Alma Rodriguez, editors. --New York, NY: Springer , c2015.
Available Online
View e-Book
Location
Online
This volume presents the MD Anderson experience in providing care and services to the rapidly growing population of cancer survivors, which is currently estimated to be 12 million in the United States and more than 25 million worldwide. As cancer survival rates have increased, it has slowly become clear that the challenges faced by people with cancer do not end with treatment but simply change. This book aims to assist community oncologists, physicians, and their staff, who care for the vast ma…
Available Online
View e-Book
Other Authors
Foxhall, Lewis E
Rodriguez, Maria Alma
Responsibility
Lewis E. Foxhall, Maria Alma Rodriguez, editors
Place of Publication
New York, NY
Publisher
Springer
Date of Publication
c2015
Physical Description
1 online resource (xiv, 460 p. : 61 illus.)
Series Title
M.D. Anderson cancer care series
ISBN
9781493909865
9781493909858 (print ed.)
Subjects (MeSH)
Neoplasms - rehabilitation
Survivors
Abstract
This volume presents the MD Anderson experience in providing care and services to the rapidly growing population of cancer survivors, which is currently estimated to be 12 million in the United States and more than 25 million worldwide. As cancer survival rates have increased, it has slowly become clear that the challenges faced by people with cancer do not end with treatment but simply change. This book aims to assist community oncologists, physicians, and their staff, who care for the vast majority of cancer survivors, by disseminating models of surveillance for disease recurrence, screening for second primary cancers, education regarding potential late effects of treatment, and psychosocial counseling. These models have proven valuable to cancer survivors who receive care at MD Anderson.
Contents
1. Introduction -- Part I. Clinical Care Delivery -- 2. Models of Survivorship Care -- 3. Community Care Integration -- Part II. Surveillance -- 4. Adult Survivorship of Pediatric Cancers -- 5. Breast Cancer Survivorship Management -- 6. Colorectal Cancer Survivorship Management -- 7.Genitourinary Cancer Survivorship Management -- 8. Gynecologic Cancer Survivorship Management -- 9. Head and Neck Cancer Survivorship Management -- 10. Hematologic Cancer Survivorship Management: Transplantation -- 11. Hematologic Cancer Survivorship Management: Leukemia -- 12. Hematologic Cancer Survivorship Management: Lymphoma -- 13. Melanoma Survivorship Management -- 14. Thyroid Cancer Survivorship Management -- Part III. Cancer Prevention and Screening -- 15. Tobacco Cessation -- 16. Obesity and Exercise -- 17. Nutrition -- 18. Screening for Second Primary Cancers -- Part IV. Long-Term and Late Effects -- 19. Cardiovascular Issues -- 20. Cognitive Function -- 21. Endocrinologic Issues -- 22. Fatigue -- 23. Immunologic Issues -- 24. Rehabilitation -- 25. Sexuality -- Part V. Other Crosscutting Issues -- 26. Legal Issues -- 27. Communication between Patients and Health Care Providers -- 28. Integrative Oncology.
Format
e-Book
Location
Online
Less detail

Advancing the Science of Cancer in Latinos

https://libcat.nshealth.ca/en/permalink/provcat44707
Amelie G. Ramirez, Edward J. Trapido, editors. --Cham: SpringerOpen , c2020.
Available Online
View e-Book
Access
Open access
Location
Online
This open access book gives an overview of the sessions, panel discussions, and outcomes of the Advancing the Science of Cancer in Latinos conference, held in February 2018 in San Antonio, Texas, USA, and hosted by the Mays Cancer Center and the Institute for Health Promotion Research at UT Health San Antonio. Latinos – the largest, youngest, and fastest-growing minority group in the United States – are expected to face a 142% rise in cancer cases in coming years. Although there has been substa…
Available Online
View e-Book
Other Authors
Ramirez, Amelie G.
Trapido, Edward J.
Responsibility
Amelie G. Ramirez, Edward J. Trapido, editors
Place of Publication
Cham
Publisher
SpringerOpen
Date of Publication
c2020
Physical Description
1 online resource (xvii, 329 p.) : 18 illus., 13 illus. in color
ISBN
9783030292867
9783030292850 (Print ed.)
9783030292874 (Print ed.)
9783030292881 (Print ed.)
Subjects (MeSH)
Health Policy
Health Promotion
Health Status Disparities
Hispanic Americans
Minority Health
Neoplasms - ethnology
Subjects (LCSH)
Health promotion
Oncology  
Social structure
Social inequality
Cancer research
Other Subjects
United States
Specialty
Population Health
Abstract
This open access book gives an overview of the sessions, panel discussions, and outcomes of the Advancing the Science of Cancer in Latinos conference, held in February 2018 in San Antonio, Texas, USA, and hosted by the Mays Cancer Center and the Institute for Health Promotion Research at UT Health San Antonio. Latinos – the largest, youngest, and fastest-growing minority group in the United States – are expected to face a 142% rise in cancer cases in coming years. Although there has been substantial advancement in cancer prevention, screening, diagnosis, and treatment over the past few decades, addressing Latino cancer health disparities has not nearly kept pace with progress. The diverse and dynamic group of speakers and panelists brought together at the Advancing the Science of Cancer in Latinos conference provided in-depth insights as well as progress and actionable goals for Latino-focused basic science research, clinical best practices, community interventions, and what can be done by way of prevention, screening, diagnosis, and treatment of cancer in Latinos. These insights have been translated into the chapters included in this compendium. The chapters summarize the presentations and include current knowledge in the specific topic areas, identified gaps, and top priority areas for future cancer research in Latinos. Advancing the Science of Cancer in Latinos proves to be an indispensable resource offering key insights into actionable targets for basic science research, suggestions for clinical best practices and community interventions, and novel strategies and advocacy opportunities to reduce health disparities in Latino communities. It will find an engaged audience among researchers, academics, physicians and other healthcare professionals, patient advocates, students, and others with an interest in the broad field of Latino cancer.
Contents
Part I. Introduction -- 1. Advancing the Science of Cancer in Latinos -- Part II. Genetics, Environment, Lifestyle, and Cancer -- 2. Disaggregated Hispanic Groups and Cancer: Importance, Methodology and Current Knowledge -- 3. Colorectal Cancer Disparities in Latinos: Genes vs. Environment -- Part III. Cancer Risk, Prevention, and Screening -- 4. Breast Cancer Risk and Mortality in Women of Latin American Origin -- 5. Prostate Cancer in U.S. Latinos: What Have We Learned and Where Should We Focus Our Attention -- 6. Differential Cancer Risk in Latinos: The Role of Diet -- Part IV. The Biology of Cancer Health Disparities -- 7. Biomarkers of Gastric Pre-Malignant Lesions -- 8. Molecular Subtypes and Driver Mutations in Latinos with Gastric Cancer: Implications for Etiological and Translational Research -- 9. The Biology of Breast Cancer Disparities in Hispanics: Current Knowledge, Gaps and Research Opportunities -- 10. Molecular Profiles of Breast Cancer in Hispanic/Latina -- Part V. Advances in Cancer Therapy and Clinical Trials -- 11. Biomarkers and Precision Medicine in Oncology Practice and Clinical Trials -- 12. Overcoming Barriers for Latinos on Cancer Clinical Trials -- Part VI. Cancer in the Era of Precision Medicine -- 13. Breast Cancer Precision Medicine in Hispanics/Latinas: Focus on Luminal B Tumors -- 14. Is Precision Medicine Widening Cancer Care Disparities in Latino Populations? The Rutgers Cancer Institute of New Jersey Experience -- Part VII. Cancer Outcomes and Survivorship in Latinos -- 15. A Vision for Improving Quality of Life Among Spanish-Speaking Latina Breast Cancer Survivors -- 16. Research Democracy in a Randomized Controlled Trial: Engaging Multiple Stakeholders in Patient-Centered Outcomes Research -- Part VIII. Engaging Latinos in Cancer Research -- 17. Es Tiempo: Engaging Latinas in Cervical Cancer Research -- 18. Reaching Latinos Through Social Media and SMS for Smoking Cessation -- 19. The Need for a Holistic Approach to Prevent Reproductive Cancers among US Latinas: The Potential Impact of Normalizing Sexuality and Improving Communication -- 20. Critical Steps for Engaging Hispanics in Cancer Research: Building Capacity to Enhance Participation in Biospecimen Donation with Hispanic Communities -- Part IX Charting the Future of Cancer Health Disparities Research in Latinos -- 21. Emerging Policies in US Health Care -- 22. A Way Forward: The Future of Cancer Health Disparities Research in Latinos.
Access
Open access
Format
e-Book
Location
Online
Less detail

Approach to Internal Medicine : A Resource Book for Clinical Practice

https://libcat.nshealth.ca/en/permalink/provcat39749
David Hui, Alexander A. Leung, Raj Padwal, editors. (Fourth edition) --Cham: Springer , c2016.
Available Online
View e-Book
Location
Online
This book offers an integrated symptom- and issue-based approach to internal medicine. Fully updated and revised, the Fourth Edition provides clinicians and trainees with a high-yield, evidence-based, and concise resource for everyday use, bedside teaching, and examination preparation. It presents over 250 internal medicine topics classified under 17 subspecialties. For each topic, differential diagnoses, investigations, and treatments are outlined. Comparison tables aimed at highlighting the d…
Available Online
View e-Book
Other Authors
Hui, David
Leung, Alexander A
Padwal, Raj
Responsibility
David Hui, Alexander A. Leung, Raj Padwal, editors
Edition
Fourth edition
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2016
Physical Description
1 online resource (xix, 542 p. : 9 illus., 7 illus. in color)
ISBN
9783319118215
9783319118208 (print ed.)
Subjects (MeSH)
Emergency Medicine
Evidence-Based Medicine
Abstract
This book offers an integrated symptom- and issue-based approach to internal medicine. Fully updated and revised, the Fourth Edition provides clinicians and trainees with a high-yield, evidence-based, and concise resource for everyday use, bedside teaching, and examination preparation. It presents over 250 internal medicine topics classified under 17 subspecialties. For each topic, differential diagnoses, investigations, and treatments are outlined. Comparison tables aimed at highlighting the distinguishing features between various clinical entities are featured and numerous clinical pearls and mnemonics enhance understanding of the topics. The book covers many highly important topics in medicine; for example, smoking cessation, obesity, transfusion reactions, needle stick injuries, code status discussion, interpretation of gram stain, and palliative care. Approach to Internal Medicine, Fourth Edition, continues to serve as an essential reference for every medical student, resident, fellow, practicing physician, nurse, and physician assistant.
Format
e-Book
Publication Type
Handbook
Location
Online
Less detail

The Benefits of Quitting Smoking for People with Cancer

https://libcat.nshealth.ca/en/permalink/chpams37381
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2019.
Pamphlet Number
0067
Available Online
View Pamphlet
Lists the benefits of quitting smoking for those with cancer.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document : digital, PDF file
Subjects (MeSH)
Neoplasms - prevention & control
Self Care
Smoking Cessation
Subjects (LCSH)
Cancer--Patients
Self-care, Health
Smoking cessation
Specialty
Self Care
Abstract
Lists the benefits of quitting smoking for those with cancer.
Notes
This resource has been adapted from 'The Benefits of Quitting Smoking for People with Cancer” with the permission from Cancer Care Ontario, the Canadian Cancer Society Smokers’ Helpline and CancerContol Alberta.
Pamphlet Number
0067
Less detail

Break free : directional paper of the National Program to Reduce Tobacco Use in Canada

https://libcat.nshealth.ca/en/permalink/provcat52903
[prepared by the Consultation, Planning and Implementation Committee]. --[Ottawa, ON]: [Health and Welfare Canada] , 1987.
Call Number
QV 137 B828 1987
Location
IWK Health Sciences Library
Call Number
QV 137 B828 1987
Corporate Author
Health and Welfare Canada. Consultation, Planning and Implementation Committee
Responsibility
[prepared by the Consultation, Planning and Implementation Committee]
Place of Publication
[Ottawa, ON]
Publisher
[Health and Welfare Canada]
Date of Publication
1987
Physical Description
28 p. : ill.
Subjects (MeSH)
Health Policy
Smoking Cessation
Smoking Reduction
Tobacco Use Disorder - prevention & control
Canada
Notes
Cover title.
Format
Book
Location
IWK Health Sciences Library
Copies
1
Loan Period
2 weeks
Less detail

Breastfeeding telephone triage and advice

https://libcat.nshealth.ca/en/permalink/provcat30750
Maya Bunik. --[Chicago, IL]: American Academy of Pediatrics , c2013.
Available Online
View e-Book
Location
Online
Breastfeeding Telephone Triage and Advice is an all-new decision support tool developed to help nurses, lactation professionals, and other medical professionals confidently advise breastfeeding mothers. Created by one of the field's foremost authorities, Maya Bunik, MD, MSPH, FABM, FAAP, it is designed to be used in tandem with the acclaimed American Academy of Pediatrics bestseller Pediatric Telephone Protocols. This volume introduces 60 practice-tested protocols presented on easy-reading doub…
Available Online
View e-Book
Author
Bunik, Maya
Other Authors
American Academy of Pediatrics
Responsibility
Maya Bunik
Place of Publication
[Chicago, IL]
Publisher
American Academy of Pediatrics
Date of Publication
c2013
Physical Description
xiii, 94 p. : ill.
ISBN
9781581107630
9781581107449 (print ed.)
Subjects (MeSH)
Breast Feeding
Lactation
Telephone
Triage - methods
Abstract
Breastfeeding Telephone Triage and Advice is an all-new decision support tool developed to help nurses, lactation professionals, and other medical professionals confidently advise breastfeeding mothers. Created by one of the field's foremost authorities, Maya Bunik, MD, MSPH, FABM, FAAP, it is designed to be used in tandem with the acclaimed American Academy of Pediatrics bestseller Pediatric Telephone Protocols. This volume introduces 60 practice-tested protocols presented on easy-reading double-column pages to help simplify targeted triage decision-making.
Contents
Alcohol Use -- Allergy; B; Biting Breast Onset at 6 Months -- Breast Mass; Breast Mass -- Breast Pain -- Breastfeeding in the First Few Weeks: Simplify Your Life (Advice Only) -- C; Clicking or Noisy Nursing -- Color Change of Human Milk -- Constipation in the Breastfed Baby -- Contraception, Lactation Amenorrhea Method (Advice Only) -- Cosleeping/Bed-sharing and Breastfeeding (Advice Only) -- D; Distraction, Onset at 4 Months -- E; Emotional Symptoms With Letdown -- Engorgement; Engorgement -- Environmental Exposures and Toxins -- Exclusive Pumping -- Expression of Human Milk: Pumping, Parts and Cleaning Equipment, Hand Expression (Advice Only) -- -- F; Fathers (Advice Only) -- Feeding More Frequently -- Feeding the Baby With Cleft Lip and/or Palate; Feeding the Baby With Cleft Lip and/or Palate -- Feeding the Baby With Hypotonia -- Feeding the Baby With Trisomy 21 (Down Syndrome) -- Fortification of Human Milk Recipes (Advice Only) -- Fussiness, Colic, and Crying in the Breastfed Baby -- G; Gassiness in the Breastfed Baby -- J; Jaundice, Newborn -- L; Late Preterm Newborn -- Lifestyle or Personal Care Questions (Advice Only) -- Long-term Breastfeeding (Advice Only) -- Low Milk Supply -- M; Maternal Anesthesia/Analgesia (Advice Only) -- Maternal Contraindications/Causes for Concern with Breastfeeding (Advice Only) -- Maternal Illnesses (Advice Only) -- Maternal Ingestion of Foods and Herbs (Advice Only) -- Maternal Medications (Advice Only) -- Maternal Postpartum Depression -- Maternal Pospartum Vaginal bleeding -- Maternal Smoking and Cessation -- Milk Leaking from Newborn's Breast (Galactorrhea) -- Milk Stroage and Return to Work/School -- Mistaken Milk Ingestion -- Multiples (Advice Only) -- N; Newborn Contraindications to Breastfeeding (Advice Only) -- Nipple Abnormality: Flat, Inverted, Large, or Bulbous -- No Latch or Inability to Latch -- Nursing Strike or Refusal -- Nursing with Pregnancy -- O; Overactive Letdown/Overabundant Milk Supply -- P; Pacifiers and Slow-Flow Nipples (Advice Only) -- R; Referral to Local Resources (Advice Only) -- Refusing Bottle, Preferring to Nurse -- S; Sore Nipples -- Spititng Up (Reflux) -- Substances of Abuse (Illicit Drugs) -- T; Tandern Nursing -- Taste Change of Human Milk -- Tongue-tie -- V; Vitamin D Supplementation -- W; Weaning.
Format
e-Book
Publication Type
Handbook
Location
Online
Less detail

Chronic Myeloid Leukemia

https://libcat.nshealth.ca/en/permalink/provcat40239
R©diger Hehlmann, editor. --Cham: Springer , c2016.
Available Online
View e-Book
Location
Online
This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls of first-, second-, and third-line treatments; the European LeukemiaNet recommendations; management of adverse effects of tyrosine kinase inhibitors (TKI); management of CML blast crisis; management o…
Available Online
View e-Book
Other Authors
Hehlmann, R©diger
Responsibility
R©diger Hehlmann, editor
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2016
Physical Description
1 online resource (x, 255 p. : 40 illus., 39 illus. in color)
Series
Hematologic Malignancies
Series Title
Hematologic malignancies (Series)
ISBN
9783319331980
9783319331973 (print ed.)
ISSN
2197-9766
Subjects (MeSH)
Antineoplastic Agents - therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology
Abstract
This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls of first-, second-, and third-line treatments; the European LeukemiaNet recommendations; management of adverse effects of tyrosine kinase inhibitors (TKI); management of CML blast crisis; management of pregnancy in the context of CML; the role of hematopoietic cell transplantation; the current experience with TKI discontinuation; and the value of interferon in improving the outcome of TKI treatment. Various aspects of relevance to treatment outcome are discussed, including prognostic scores, molecular monitoring (principles and interlaboratory standardization), and response-related predictors of survival. Furthermore, updates are provided on the increasing prevalence of CML and its implications and on the changing cost of care for CML, taking into account the forthcoming impact of availability of generic imatinib.
Contents
1 Cytogenetics of Chronic Myeloid Leukemia (CML) -- 2 The Biology and Pathogenesis of Chronic Myeloid Leukemia -- 3 The Choice of First-Line Chronic Myelogenous Leukemia Treatment -- 4 A Review and an Update of European LeukemiaNet Recommendations for the Management of Chronic Myeloid Leukemia -- 5 Management of Adverse Events Associated with ATP-Competitive BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia -- 6 Standardization of Molecular Monitoring for Chronic Myeloid Leukemia -- 7 Epidemiology of Chronic Myeloid Leukemia -- 8 Prognostic Scores for Patients with Chronic Myeloid Leukemia Under Particular Consideration of Disease-Specific Death -- 9 Response-Related Predictors of Survival in CML -- 10 CML Blast Crisis: Implications and Management -- 11 Managing Pregnancy in Chronic Myeloid Leukemia -- 12 The Role of Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia -- 13 Discontinuation or Cessation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia Patients with Deep Molecular Response -- 14 The Interferon Alpha Revival in CML -- 15 Changing the Cost of Care for Chronic Myeloid Leukemia: The Availability of Generic Imatinib in the USA and the EU.
Format
e-Book
Location
Online
Less detail

Clinical psychopharmacology : a practical approach

https://libcat.nshealth.ca/en/permalink/provcat31339
Humberto Marin, Javier I Escóbar. --Hackensack, NJ: World Scientific Pub. Co , c2013.
Available Online
View e-Book
Location
Online
This book aims to provide comprehensive, up-to-date information on psychotropic drugs and inform clinical decisions for the treatment of mental disorders using a problem-solving approach. In order to accomplish these goals, the book has three central characteristics: it is evidence-based; it compares each individual drug with others in the same class and also those used for the same indications rather than describing them separately; it steadily draws practical conclusions and makes recommendat…
Available Online
View e-Book
Author
Marin, Humberto
Other Authors
Escóbar, Javier I
Responsibility
Humberto Marin, Javier I Escóbar
Place of Publication
Hackensack, NJ
Publisher
World Scientific Pub. Co
Date of Publication
c2013
Physical Description
1 online resource (286 p.)
ISBN
9789814343664
Subjects (MeSH)
Mental Disorders - drug therapy
Psychopharmacology
Psychotropic Drugs
Abstract
This book aims to provide comprehensive, up-to-date information on psychotropic drugs and inform clinical decisions for the treatment of mental disorders using a problem-solving approach. In order to accomplish these goals, the book has three central characteristics: it is evidence-based; it compares each individual drug with others in the same class and also those used for the same indications rather than describing them separately; it steadily draws practical conclusions and makes recommendations about how to select and use medications in the treatment of specific mental disorders. More than a textbook, it is meant to serve as a practical tool for professionals working in the mental health field.
Contents
Ch. 1. Absorption, transformation, and elimination of psychotropic medications. -- ch. 2. Neurotransmitters, receptors, and transporters. 2.1. Main types of receptors in the brain. 2.2. Neurotransmitters. 2.3. Neurotransmitter reuptake transporters -- ch. 3. Antipsychotics: a general view of therapeutic and adverse effects. 3.1. Classic antipsychotics. 3.2. New antipsychotics. 3.3. Are the new antipsychotics clinically different from the old ones? 3.4. Current concepts regarding antipsychotic action and the D[symbol] receptor. 3.5. Comparison between typical and atypical antipsychotics. 3.6. Metabolic side effects of antipsychotic drugs. 3.7. Extrapyramidal symptoms of antipsychotics. 3.8. Neuroleptic malignant syndrome. 3.9. Catatonia. 3.10. Antipsychotic-induced hyperprolactinemia. 3.11. Sexual side effects of antipsychotics. 3.12. Antihistamine adverse effects of antipsychotics. 3.13. Anticholinergic adverse effects of antipsychotics: cognitive and peripheral. 3.14. Antipsychotics and the risk of seizures. 3.15. Vascular side effects of antipsychotics. 3.16. Antipsychotics and the risk of malignant arrythmia and sudden cardiac death. 3.17. Antipsychotics and increased morbidity and mortality in patients with dementia. 3.18. Antipsychotics and suicide. 3.19. Antipsychotics and the risk of cancer -- ch. 4. Description of individual antipsychotics. 4.1. Typical antipsychotics. 4.2. Atypical antipsychotics -- ch. 5. Treatment of schizophrenia with antipsychotic medications. 5.1. Choice of an antipsychotic for the initial treatment of schizophrenia. 5.2. Dosing in the initial antipsychotic treatment of schizophrenia. 5.3. How long does it take to respond to an antipsychotic? 5.4. Monitoring antipsychotic treatment. 5.5. Maintenance of antipsychotic treatment of schizophrenia. 5.6. Combination of antipsychotic drugs in schizophrenia ("polypharmacy"). 5.7. Pharmacological management of treatment-resistant schizophrenia. 5.8. Use of long-acting injectable antipsychotics in schizophrenia -- ch. 6. Antidepressants: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. 6.1. Introduction. 6.2. Pharmacodynamics of SSRIs and SNRIs (receptor affinity). 6.3. Pharmacokinetics of SSRIs and SNRIs. 6.4. Use of SSRIs in mental disorders. 6.5. Use of SNRIs in mental disorders. 6.6. Dosing of SSRIs and SNRIs. 6.7. Adverse effects of SSRIs and SNRIs. 6.8. Discontinuation syndrome with SSRIs and SNRIs. 6.9. Toxicity of SSRIs and SNRIs and serotonin syndrome. 6.10. Precautions with SSRIs and SNRIs. 6.11. Use of SSRIs and SNRIs during pregnancy and lactation -- ch. 7. Bupropion. 7.1. Introduction. 7.2. Pharmacology. 7.3. Approved indications and other possible uses. 7.4. Dosing and available forms of bupropion. 7.5. Side effects and adverse reactions. 7.6. Contraindications, warnings, and precautions. 7.7. Use of bupropion during pregnancy -- Ch. 8. Mirtazapine, trazodone, and nefazodone. 8.1. Mirtazapine. 8.2. Trazodone. 8.3. Nefazodone -- ch. 9. Monoamine oxidase inhibitors and tricyclic antidepressants. 9.1. Monoamine oxidase inhibitors. 9.2. Tricyclic antidepressants -- ch. 10. Individualized treatment of depression. 10.1. Patient factors to consider. 10.2. Second-generation antidepressants: doses and duration. 10.3. Hypnotics and other symptom-specific medications. 10.4. Partial response to antidepressant treatment: what to do? 10.5. No response to initial antidepressant treatment: what to do? 10.6. What about adding atypical antipsychotics in the initial treatment of depression? 10.7. Other non-antidepressant drugs recently tried in depression. 10.8. Once the patient gets better, how to stop antidepressant treatment? -- ch. 11. Benzodiazepines, buspirone, and miscellaneous medications used in anxiety disorders. 11.1. Benzodiazepines. 11.2. Buspirone. 11.3. Antiepileptic drugs. 11.4. Antihistamines. 11.5. Prazosin for nightmares in post-traumatic stress disorder. 11.6. Do antipsychotics have a role in anxiety? 11.7. Beta-blockers -- ch. 12. Medication treatment of anxiety disorders. General considerations prior to starting drug treatment. Other considerations. 12.1. Approved and potential uses of antidepressants and other medications. 12.2. Drug treatment of individual anxiety disorders -- ch. 13. Medications used in the treatment of mania. 13.1. Lithium. 13.2. Antipsychotics. 13.3. Carbamazepine. 13.4. Oxcarbazepine. 13.5. Valproic acid (divalproex, valproate). 13.6. Tamoxifen -- ch. 14. Medications used in bipolar depression, mixed states, and rapid cycling. 14.1. Electroconvulsive therapy. 14.2. Lithium. 14.3. Quetiapine. 14.4. Lamotrigine. 14.5. Valproate. 14.6. Antidepressants. 14.7. Ketamine in bipolar and treatment-resistant depression. 14.8. Pharmacological treatment of mixed states and rapid cycling bipolar disorder -- ch. 15. Medications used in the treatment of insomnia. 15.1. General rules. 15.2. Antihistamines as hypnotics. 15.3. Sedating antidepressants (trazodone and mirtazapine). 15.4. Melatonin receptor agonists. 15.5. GABA receptor agonists -- ch. 16. Medications used in the treatment of attention disorders. 16.1. Stimulant medications (psychostimulants). 16.2. Atomoxetine. 16.3. Bupropion. 16.4. Modafinil. 16.5. [symbol]-adrenergic agonists (guanfacine and clonidine) -- ch. 17. Medications used in the treatment of dementia. 17.1. Side effects. 17.2. Pharmacokinetics. 17.3. Pointers for clinical use -- ch. 18. Medications used in smoking cessation and alcohol use disorders. 18.1. Medications used in the treatment of nicotine dependence (smoking cessation). 18.2. Medications used in the treatment of alcohol use disorders -- ch. 19. Drug-drug interactions. 19.1. Pharmacokinetic drug-drug interactions. 19.2. Pharmacodynamic DDIs involving psychotropic drugs. 19.3. Drug-drug Interactions due to cumulative toxicity. 19.4. Drug-drug interactions related to food supplements and substances of abuse.
Format
e-Book
Location
Online
Less detail

Clinical Relevance of Genetic Factors in Pulmonary Diseases

https://libcat.nshealth.ca/en/permalink/provcat43400
Takeshi Kaneko, editor. --Singapore: Springer , c2018.
Available Online
View e-Book
Location
Online
This book describes the underlying genetic basis of common pulmonary diseases and discusses their pathogenesis and pathophysiology. These insights provide the basis for understanding different subtypes and phonotypes, and will promote better treatment strategies and individualized medicine. The book provides new and valuable information for the development of the areas of study, as well as practical guidelines for clinicians engaged in treating pulmonary diseases. This volume of the Respiratory…
Available Online
View e-Book
Other Authors
Kaneko, Takeshi
Responsibility
Takeshi Kaneko, editor
Place of Publication
Singapore
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (ix, 344 p.) : 55 illus., 36 illus. in color
Series
Respiratory Disease Series: Diagnostic Tools and Disease Managements
Series Title
Respiratory disease series
ISBN
9789811081446
9789811081439 (print ed.)
9789811081453 (print ed.)
ISSN
2509-5552
Subjects (MeSH)
Genetic Predisposition to Disease
Lung Diseases - diagnosis
Lung Diseases - genetics
Lung Diseases - physiopathology
Precision Medicine
Risk Factors
Specialty
Genetics, Medical
Pulmonary Medicine
Abstract
This book describes the underlying genetic basis of common pulmonary diseases and discusses their pathogenesis and pathophysiology. These insights provide the basis for understanding different subtypes and phonotypes, and will promote better treatment strategies and individualized medicine. The book provides new and valuable information for the development of the areas of study, as well as practical guidelines for clinicians engaged in treating pulmonary diseases. This volume of the Respiratory Disease Series : Diagnostic Tools and Disease Managements will broaden the understanding of beginning and experienced researchers and clinicians who treat pulmonary diseases. Moreover, residents and clinicians engaged in medical oncology will find it a valuable guide to support them in their day-to-day work.
Contents
Part I. Introduction -- 1. Clinical development of genomic medicine in pulmonary diseases: Are genetic factors enough to determine the phenotype and inheritance of pulmonary diseases? -- 2. Statistical approaches and strategies for complex diseases - Overview - : What is the rationale for the genome-wide approach to understand complex diseases - its application and limitations -- Part II. Genetic Disorders in Pulmonary Disease -- 3. Bronchial asthma: Is asthma inherited? -- 4. COPD - Hereditary (A1-AT) and Non-hereditary: What are the roles of genetic factors in the pathogenesis of COPD? -- 5. Smoking behavior and cessation (nicotine addiction): Are genetic factors involved in smoking behavior? -- 6. Cystic fibrosis, Primary ciliary dyskinesia and Diffuse panbronchiolitis - Hereditary and Non-Hereditary: What are the roles of genetic factors in the pathogenesis of these diseases? -- 7. Pulmonary Fibrosis -Hereditary and Nonhereditary: What are the role of genetic factors in the pathogenesis of pulmonary fibrosis? -- 8. Other diffuse lung diseases - Diffuse cystic lung diseases (LAM, TSC, BHD), Sarcoidosis, Pulmonary alveolar proteinosis, and Pulmonary alveolar microlithiasis: What are the roles of genetic factors in the pathogenesis of these diseases? -- 9. Pulmonary vascular diseases. Pulmonary hypertension and HHT: What are the roles of genetic factors in the pathogenesis of pulmonary vascular diseases? -- 10. Mycobacterial infection—TB and NTM: What are the roles of genetic factors in the pathogenesis of mycobacterial infection? -- 11. Pulmonary malignancies (1). Lung cancer: What are the roles of genetic factors in lung cancer pathogenesis? -- 12. Pulmonary malignancies (2). Mesothelioma: What are the Roles of Genetic Factors in the Pathogenesis of Mesothelioma? -- 13. Genetic Factors in Sleep Disorders: What are the roles of genetic factors in the pathogenesis of sleep disorders? -- 14. Pharmacokinetics, pharmacodynamics, and toxicities: What should we know about genetic factors that affect the pharmacotherapy of pulmonary diseases? -- Part III. Oncogenic Driver Mutation (Somatic Mutations) in Lung Cancer -- 15. EGFR: How important is EGFR mutation status in the management of lung cancer? -- 16. ALK, and others: How important are ALK, and other mutations in the management of lung cancer? -- Part IV. Current Topics -- 17. Application of high-throughput technologies in personal genomics: How is the progress in personal genome service? -- 18. Nucleic acid amplification-based diagnostics for pulmonary diseases : What is the current state and perspectives of nucleic acid amplification technologies used in diagnostics associated with pulmonary diseases?
Format
e-Book
Location
Online
Less detail

Difficult Decisions in Bariatric Surgery

https://libcat.nshealth.ca/en/permalink/provcat46490
John Alverdy, Yalini Vigneswaran, editors. --Cham: Springer , c2021.
Available Online
View e-Book
Access
NEW Springer 2021
Location
Online
This book provides a practical guide to decision making within bariatric surgery. Through uniform and well-structured chapters, topics relating to patient selection, preoperative preparation, the ethics of bariatric surgery, choice of procedure, complications, late failure and management, malabsorptive procedures, and pediatric bariatric surgery are discussed and examined. Difficult Decisions in Bariatric Surgery aims to help readers navigate an increasingly complex surgical specialty and come …
Available Online
View e-Book
Other Authors
Alverdy, John
Vigneswaran, Yalini
Responsibility
John Alverdy, Yalini Vigneswaran, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2021
Physical Description
1 online resource (viii, 438 p.) : 12 illus., 9 illus. in color
Series
Difficult Decisions in Surgery: An Evidence-Based Approach
Series Title
Difficult decisions in surgery
ISBN
9783030553296
9783030553289 (Print ed.)
9783030553302 (Print ed.)
9783030553319 (Print ed.)
ISSN
2198-7750
Subjects (MeSH)
Bariatric Surgery - methods
Patient Care Planning
Specialty
Bariatric Medicine
Surgical Procedures, Operative
Abstract
This book provides a practical guide to decision making within bariatric surgery. Through uniform and well-structured chapters, topics relating to patient selection, preoperative preparation, the ethics of bariatric surgery, choice of procedure, complications, late failure and management, malabsorptive procedures, and pediatric bariatric surgery are discussed and examined. Difficult Decisions in Bariatric Surgery aims to help readers navigate an increasingly complex surgical specialty and come to reasoned and evidence-based conclusions. This book is of interest to practicing and trainee surgeons, endocrinologists, endoscopists, and pediatricians.
Contents
Part I. Introductory Materials -- 1. “A Patient, a Surgeon, and an Insurance Agent Walk into a Bar…” -- 2. Evidence-Based Medicine and Decision Making -- Part II. Patient Selection -- 3. Bariatric Surgery for Uncontrolled Hypertension -- 4. Diabetes as an Indication for Bariatric Surgery -- 5. Bariatric Procedure Selection in Diabetics -- 6. Should Patients with Obesity Hypoventilation Syndrome Undergo Bariatric Surgery -- 7. Bariatric Surgery in Heart Failure -- 8. Bariatric Surgery in Those with Coronary Artery Disease -- 9. What Are the Nutritional “Red Flags” to Look Out for Prior to Bariatric Surgery? -- 10. Are There Psychiatric Diagnoses That Preclude Safe Bariatric Surgery? -- 11. Does Weight Loss Prior to Surgery Accurately Predict Success Following Bariatric Surgery? -- 12. Optimization Prior to Knee and Hip Arthroplasty as an Indication for Bariatric Surgery -- Part III. Preoperative Preparation -- 13. The Ideal Preoperative Bariatric Surgery Diet -- 14. Is Routine Upper Endoscopy and H. pylori Testing Indicated in Advance of Bariatric Surgery? -- 15. Manometry is Useful Prior to Bariatric Surgery -- 16. Smoking Cessation Is Essential Prior to Bariatric Surgery -- Part IV. Ethics and Bariatric Surgery -- 17. Is the Insurance Requirement for Supervised Weight Loss Prior to Bariatric Surgery an Ethical Strategy to Prevent Non-compliant Patients from Undergoing Surgery? -- 18. Ethical Concerns of Bariatric Surgery in the Pediatric Population -- Part V. Choice of Bariatric Procedure -- 19. Adjustable Gastric Banding: Why Did It Fail? -- 20. What Is the Role of Bariatric Surgery in the Treatment of Nonalcoholic Steatohepatitis? -- 21. Is Roux-en-Y Gastric Bypass Less Safe Than Sleeve Gastrectomy? -- 22. The National Shift to Sleeve Gastrectomy: Long-Term Disappointment and Recidivism or Patient Preference? -- 23. Single-Stage Duodenal Switch is Better than Two-Stage -- Part VI. Complications -- 24. Stenting for Leaks After Sleeve Gastrectomy -- 25. Reoperation for Repair of Anastomotic Leaks and Staple Line Disruptions -- 26. Gastric Sleeve Stricture, Twist or Kink, Now What? -- 27. Hiatal Hernia Complicating Bariatric Surgery -- 28. Management of GERD in Duodenal Switch -- Part VII. Late Failure -- 29. Endoscopic Management of the Dilated Gastrojejunal Anastomosis -- 30. Suboptimal Weight Loss and Weight Regain: Is it Prime Time for Pharmacotherapy? -- 31. Does Resizing the Gastric Pouch Aid in Weight Loss? -- 32. Does Stoma Size Matter After Gastric Bypass? -- Part VIII. The Pediatric Population -- 33. Indications, Choice of Operations and Outcomes of Metabolic and Bariatric Surgery in Children -- 34. Pediatric Bariatric Surgery and Sexual Developmental Milestones -- 35. Which Surgical Specialist Should Perform Metabolic Bariatric Surgery in Children and Adolescents? -- Part IX. The Future -- 36. Deep Brain Stimulation as a Treatment for Obesity -- 37. How Manipulating the Microbiome Can Affect the Outcome Following Bariatric Surgery.
Access
NEW Springer 2021
Format
e-Book
Location
Online
Less detail

Difficult Decisions in Thoracic Surgery : An Evidence-Based Approach

https://libcat.nshealth.ca/en/permalink/provcat45442
Mark K. Ferguson, editor. (Fourth edition) --Cham: Springer , c2020.
Available Online
View e-Book
Location
Online
This updated volume provides a practical guide to decision making within thoracic surgery. Focussed chapters contain pithy analyses and recommendations that allow useful information to be identified at a glance. All new chapters bring insight into the challenges faced operating on the lung, esophagus, diaphragm, airway, pleaura, mediastinum, and chest wall. Difficult Decisions in Thoracic Surgery aims to help the reader navigate the complexities of thoracic surgery through clearly formatted and…
Available Online
View e-Book
Other Authors
Ferguson, Mark K.
Responsibility
Mark K. Ferguson, editor
Edition
Fourth edition
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2020
Physical Description
1 online resource (xv, 705 p.) : 19 illus., 17 illus. in color
Series
Difficult Decisions in Surgery: An Evidence-Based Approach
Series Title
Difficult decisions in surgery
ISBN
9783030474041
9783030474034 (Print ed.)
9783030474058 (Print ed.)
9783030474065 (Print ed.)
ISSN
2198-7750
Subjects (MeSH)
Clinical Decision-Making
Thoracic Surgery
Treatment Outcome
Specialty
Thoracic Surgery
Abstract
This updated volume provides a practical guide to decision making within thoracic surgery. Focussed chapters contain pithy analyses and recommendations that allow useful information to be identified at a glance. All new chapters bring insight into the challenges faced operating on the lung, esophagus, diaphragm, airway, pleaura, mediastinum, and chest wall. Difficult Decisions in Thoracic Surgery aims to help the reader navigate the complexities of thoracic surgery through clearly formatted and evidence-based chapters. The book is relevant to practicing and trainee surgeons, as well as medical professionals working within thoracic surgery.
Contents
1. Introduction - 2. Evidence Based Medicine: Quality of Evidence and Evaluation Systems -- 3. Decision Analytic Techniques and Other Decision Processes -- 4. Decision Making: The Surgeon’s Perspective -- 5. Involving Patients in Difficult Decisions About Having Surgery -- Part I. Lung -- 6. EBUS vs. Mediastinoscopy for Initial Pathologic Mediastinal Staging in NSCLC -- 7. Does Preoperative Smoking Cessation Reduce Surgical Morbidity After Lung Resection? -- 8. Is Low Tech as Good as High Tech Exercise Testing in Assessing Healthy Candidates for Lung Resection? -- 9. Does Assessment of Frailty and Sarcopenia in Lung Resection Candidates Affect Patient Selection? -- 10. Can Frailty and Sarcopenia Be Mitigated in Lung Resection Candidates? -- 11. Is Antibiotic Prophylaxis Necessary for Major Lung Resection? -- 12. Uniportal Versus Multiportal VATS Lobectomy -- 13. Robotic Versus Video-Assisted Thoracoscopic Surgery (VATS) Major Lung Resection for Early Stage NSCLC -- 14. Does Blood Patch for Persistent Postoperative Air Leak Reduce Air Leak Duration -- 15. Is Resection of Persistent N2 Disease After Induction Therapy Effective? -- 16. N2 Disease Discovered at the Time of Vats Lung Resection: Resect or Abort? -- 17. Does Induction Immunotherapy Confer Increased Operative Risk for Lung Resection? -- 18. Does an Enhanced Recovery Program for Lobectomy Improve Surgical Outcomes? -- 19. Resection vs. SBRT for Stage I NSCLC in Patients with Good Pulmonary Function -- 20. Do Endobronchial Valves Assist in Resolution of Postoperative Persistent Air Leak? -- 21. Is Long-Term Surveillance Effective After Resection of Stage I Non-small Cell Lung Cancer? -- 22. Does ECMO for Lung Failure in ICU Patients Improve Survival? -- 23. Does Local Therapy for Oligometastatic Disease in Lung Cancer Patients Improve Survival? -- 24. Is Pulmonary Metastasectomy Effective in Prolonging Survival? -- Part II. Esophagus -- 25. Surgical Resection Versus Endoscopic Therapy for T1bN0 Esophageal Adenocarcinoma -- 26. Does Induction Therapy for T2N0 Esophageal Adenocarcinoma Patients Improve Survival? -- 27. Can Frailty and Sarcopenia Be Mitigated in Esophagectomy Candidates? -- 28. Do Enhanced Recovery Programs for Esophagectomy Patients Improve Outcomes? -- 29. Does Jejunostomy Tube Feeding Improve Outcomes After Esophagectomy? -- 30. Surgery Versus Definitive Chemoradiotherapy for Regionally Advanced Esophageal Squamous Cell Cancer -- 31. Robotic Minimally Invasive Esophagectomy (RAMIE) vs. Open Esophagectomy (OE) for Resectable Esophageal Cancer -- 32. Two-Field vs. Three-Field Lymphadenectomy for Esophageal Adenocarcinoma -- 33. What Is the Appropriate Extent of Lymph Node Dissection in Esophageal Cancer -- 34. Salvage Esophagectomy for Persistent or Recurrent Disease After Chemoradiation -- 35. Early Oral Feeding After Esophagectomy -- 36. Stent vs. Primary Repair for Esophageal Perforation -- 37. Endoluminal Vacuum Therapy vs. Stenting for Esophageal Anastomotic Leaks -- 38. Thoracoscopic Versus Endoscopic Therapy for Small Sub-epithelial Esophageal Tumors -- 39. Laparoscopic vs. Endoscopic Therapy for Achalasia -- 40. Laparoscopy or Endoscopic Therapy for Recurrent Symptoms from Achalasia -- 41. Laparoscopy or Thoracotomy for Symptomatic Recurrent Paraesophageal Hernia -- Part III. Diaphragm -- 42. Does Diaphragm Pacing for Bilateral Phrenic Nerve Paralysis Improve Function or Quality of Life? -- 43. Does Phrenic Nerve Reconstruction for Unilateral Diaphragm Paralysis Improve Function or Quality of Life -- 44. Is Plication for Diaphragmatic Eventration Effective in Improving Lung Function? -- Part IV. Airways -- 45. Is Long-Term Stenting for Benign Airway Obstruction Effective? -- 46. Are Engineered Tissues Useful for Tracheal Reconstruction? -- 47. Management of Positive Margins After Resection of Primary Tracheal Malignancies -- 48. Optimal Management of Posttransplant Bronchial Stenosis: Stenting or Reoperation -- Part V. Pleura and Pleural Spaces -- 49. Is tPA/DNase Effective in the Management of Pleural Empyema? -- 50. VATS vs Open Management of Pleural Empyema -- 51. Indwelling Pleural Catheters Versus Talc Pleurodesis for Recurrent Symptomatic Malignant Pleural Effusions -- 52. Quality of Life: Extended Pleurectomy/Decortication vs Extrapleural Pneumonectomy -- Part VI. Mediastinum -- 53. Does Thymectomy Improve Outcomes in Patients with Nonthymomatous Myasthenia Gravis? -- 54. Magnetic Resonance Imaging for Evaluation of Suspected Encapsulated Thymoma -- 55. Robotic vs. Thoracoscopic Thymectomy for Thymoma -- 56. VATS for Resection of Mediastinal Parathyroid Adenomas -- 57. Thymectomy in the Setting of Pleural Metastasis -- 58. Sympathectomy for Malignant Ventricular Arrhythmias -- 59. The Extent of Surgery for Palmar Hyperhidrosis -- Part VII. Chest Wall -- 60. Synthetic Versus Biologic Reconstruction of Bony Chest Wall Defects -- 61. Traumatic Rib Fracture in the Absence of Flail Chest: Conservative Therapy or Surgical Fixation? -- 62. Is Surgical Management of Flail Chest Effective? -- 63. Epidural vs Regional Blocks for VATS and Thoracotomy -- 64. The Nuss Procedure Versus the Modified Ravitch Repair for Pectus Excavatum in Adults.
Format
e-Book
Location
Online
Less detail

Difficult decisions in thoracic surgery : an evidence-based approach

https://libcat.nshealth.ca/en/permalink/provcat33265
Mark K. Ferguson, editor. (Third edition) --London: Springer , c2014.
Available Online
View e-Book
Location
Online
The third edition of Difficult Decisions in Thoracic Surgery: An Evidence-Based Approach, devotes itself to looking at questions and decisions in general thoracic surgery that are difficult or controversial. Focused topics are explored, and readers will find pithy analyses and recommendations which are carefully given in accordance with the level of supporting evidence available. Written by recognized experts in the field, Difficult Decisions in Thoracic Surgery: An Evidence-Based Approach 3rd …
Available Online
View e-Book
Other Authors
Ferguson, Mark K
Responsibility
Mark K. Ferguson, editor
Edition
Third edition
Place of Publication
London
Publisher
Springer
Date of Publication
c2014
Physical Description
1 online resource (xxi, 787 pages)
Series Vol.
1
Series Title
Difficult decisions in surgery
ISBN
9781447164043 (electronic bk.)
9781447164036
Subjects (MeSH)
Clinical Decision-Making
Thoracic Surgical Procedures
Abstract
The third edition of Difficult Decisions in Thoracic Surgery: An Evidence-Based Approach, devotes itself to looking at questions and decisions in general thoracic surgery that are difficult or controversial. Focused topics are explored, and readers will find pithy analyses and recommendations which are carefully given in accordance with the level of supporting evidence available. Written by recognized experts in the field, Difficult Decisions in Thoracic Surgery: An Evidence-Based Approach 3rd edition is a timely reference source for practicing surgeons, surgeons in training, and educators that describes the recommended ideal approach, rather than customary care, in selected clinical situations.
Contents
Introduction -- Evidence Based Medicine: Quality of Evidence and Evaluation Systems -- Decision Analytic Techniques and Other Decision Processes -- Decision Making: The Surgeon's Perspective -- Decision Making: The Patient's Perspective -- Indications for Pretreatment Pathologic Mediastinal Staging in Non-small Cell Lung Cancer -- Preoperative Smoking Cessation for Lung Resection Patients -- High Tech Exercise Testing in Assessing Candidates for Lung Resection -- Management of Perioperative Anticoagulation in Lung Resection -- Perioperative Arrhythmia Prophylaxis for Major Lung Resection -- VATS Versus Open Lobectomy for Stage I or II NSCLC -- Robotic-Assisted Thoracoscopic Surgery (RATS) Versus Video-Assisted Thoracoscopic Surgery (VATS) Lobectomy for Stage I or II Non-small Cell Lung Cancer -- Lobectomy After Induction Therapy for NSCLC in the Presence of Persistent N2 Disease -- Pneumonectomy After Induction Therapy for Non-small Cell Lung Cancer -- Resection Versus SBRT for Stage I Non-small Cell Lung Cancer in Patients with Good Pulmonary Function -- Digital Drainage Systems After Major Lung Resection -- Management of Persistent Post-operative Alveolar Air Leak -- Surveillance After Resection of Stage I Non Small Cell Lung Cancer -- Support Therapy for Lung Failure: The Utility of Device Therapy -- Extracorporeal Support for Lung Grafts Prior to Transplantation -- Pulmonary Metastasectomy -- Optimal Therapy for Barrett High Grade Dysplasia -- Preoperative Chemo Versus Chemoradiotherapy for Regionally Advanced Esophageal Adenocarcinoma -- The Role of Surgery in the Management of Regionally Advanced Esophageal Squamous Cell Cancer -- Optimal Surgical Approach to Esophagectomy for Distal Esophageal Adenocarcinoma -- Regional Extent of Lymphadenectomy for Esophageal Cancer -- Optimal Lymph Node Dissection in Esophageal Cancer -- Salvage Esophagectomy for Persistent or Recurrent Disease After Definitive Chemoradiotherapy -- Gastric Emptying Procedure After Esophagectomy -- Postoperative Adjuvant Therapy After Resection of Regionally Advanced Esophageal Cancer -- Prophylactic Antireflux Surgery in Lung Transplantation -- Surgical Versus Endoscopic Management for Esophageal Perforations -- Stents for Esophageal Anastomotic Leak -- Management of Small Esophageal GIST Tumors -- Surgery for Minimally Symptomatic Pulsion Diverticula of the Thoracic Esophagus -- Partial Versus Total Fundoplication for GERD in Patients with Normal Esophageal Motility -- Diaphragm Pacing -- Minimally Invasive Versus Open Repair of Giant Paraesophageal Hernia -- Synthetic Reinforcement of Diaphragm Closure for Large Hiatal Hernia Repair -- Diaphragmatic Plication for Eventration -- Management of Minimally Symptomatic Recurrent Hiatal Hernia -- Stenting for Benign Airway Obstruction -- Bioengineered Tissues for Tracheal Reconstruction -- Percutaneous Versus Standard Tracheostomy in the Critically Ill Adult -- Carinal Resection for Non Small Cell Lung Cancer -- Management of Persistent Postoperative Air Leaks -- Fibrinolytics for Managing Pleural Empyema -- VATS Versus Open Management of Pleural Empyema -- Optimal Management of Symptomatic Malignant Pleural Effusion -- Pleurectomy Versus Radical Pleuropneumonectomy for Malignant Pleural Mesothelioma -- Surgical and Medical Therapy for Malignant Pleural Mesothelioma -- Extended Versus Standard Thymectomy for Myasthenia Gravis -- Optimal Approach for Resection of Encapsulated Thymoma: Open Versus VATS -- Robotic Versus VATS Thymectomy for Encapsulated Thymoma -- Video Mediastinoscopy Versus Standard Mediastinoscopy -- Debulking for Extensive Thymoma -- Surgery for Palmar Hyperhidrosis: Patient Selection and Extent of Surgery -- Synthetic Versus Biologic Reconstruction of Bony Chest Wall Defects -- Management of Flail Chest -- Management of Pectus Deformities in Adults.
Format
e-Book
Location
Online
Less detail

Disease interrupted : tobacco reduction and cessation

https://libcat.nshealth.ca/en/permalink/provcat25915
Charl Els, Diane Kunyk, Peter Selby, editors. --[s.l.]: CreateSpace Independent Publishing Platform , 2012.
Call Number
WM 290 D611 2012
Location
Halifax Infirmary
Dickson Building
Nova Scotia Hospital
Yarmouth Regional Hospital
Call Number
WM 290 D611 2012
Other Authors
Els, Charl
Kunyk,Diane
Selby, Peter
Responsibility
Charl Els, Diane Kunyk, Peter Selby, editors
Place of Publication
[s.l.]
Publisher
CreateSpace Independent Publishing Platform
Date of Publication
2012
Physical Description
325 p.
ISBN
9781467912938
Subjects (MeSH)
Nicotine - pharmacology
Smoking - epidemiology
Smoking Cessation
Smoking Cessation Agents
Smoking Cessation Products
Tobacco - adverse effects
Tobacco Use Cessation Devices
Tobacco Use Cessation - methods
Tobacco Use Disorder - prevention & control
Format
Book
Location
Halifax Infirmary
Dickson Building
Nova Scotia Hospital
Yarmouth Regional Hospital
Copies
4
Loan Period
3 weeks use
Less detail

The economics of cancer care

https://libcat.nshealth.ca/en/permalink/provcat27249
Nick Bosanquet, Karol Sikora. --Cambridge, UK: Cambridge University Press , 2006.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Bosanquet, Nicholas
Other Authors
Sikora, Karol
Responsibility
Nick Bosanquet, Karol Sikora
Place of Publication
Cambridge, UK
Publisher
Cambridge University Press
Date of Publication
2006
Physical Description
v, 185 p.
ISBN
6610437211 (electronic bk.)
Subjects (MeSH)
Neoplasms - economics
Economics, Medical
Contents
Cover -- Contents -- 1 The challenge of cancer -- Introduction -- Why the economics of cancer care deserve urgent attention -- The economic future of cancer care -- Incidence of cancer set to increase -- Prevalence of cancer set to increase -- Technological advances -- New chemotherapy drugs -- Individual cancer-risk assessment -- Paying for cancer care -- Projection of the future in cancer care -- Societal and political pressures -- Wealth and cancer incidence -- Longevity and wealth -- Aims of this book -- REFERENCES -- 2 Prevention -- Introduction -- The economics of prevention: the balance sheet so far -- New targets -- New initiatives -- Tobacco control in the UK -- Tobacco control in Europe -- The economics of prevention: future -- Marketing smoking cessation -- Diet and cancer -- Cancer and infections -- Tailored chemoprevention and its economic consequences -- Cancer genetics -- REFERENCES -- 3 Screening -- Introduction -- False positives -- Bias -- Cervical cancer -- The United Kingdom -- Australia -- Finland -- France -- Germany -- United States of America -- Breast cancer screening -- United Kingdom -- Australia -- United States of America -- Colo-rectal cancer screening -- Conclusions -- REFERENCES -- 4 Diagnostics -- Introduction -- Transmitting information on new diagnostic techniques -- Imaging -- Future predictions for imaging -- Funding new technology -- Functional imaging -- Human eye versus computer recognition systems -- Improved diagnostics will increase prevalence -- Combination therapy -- The new economic challenges of imaging and diagnostics -- The economic constraints -- REFERENCES -- 5 Surgery -- Principle drivers in developing surgery -- Techniques leading to less invasive surgery -- Prophylactic surgery -- Cancer as a chronic, controllable disease -- Computer-assisted surgery -- Surgery in 2025 -- New training requirements -- Predicting future costs of cancer surgery -- Re-engineering surgery: summary -- REFERENCES -- 6 Radiotherapy -- Technical advances in radiotherapy -- Radiotherapy: where is its place in the plethora of cancer treatments? -- The challenge for radiotherapy -- Advances in radiotherapy -- Predictive testing -- Economic consequences of predictive testing -- Intensive modulated radiotherapy -- Tomotherapy -- Ion therapy -- Robotics -- Boron neutron capture therapy -- Nanotechnology -- Economic constraints -- REFERENCES -- 7 Chemotherapy -- Generic chemotherapy drugs -- The therapeutic agenda -- How effective is chemotherapy? -- Clinical trials for new chemotherapies -- Translational research -- Molecular signatures -- A toolkit for early cancer drug development -- Adapting to changing technology -- Demand and supply of chemotherapy -- Possible scenarios for the future of chemotherapy -- How does chemotherapy affect survival rates? -- Predictions for evaluating the effectiveness o
Format
e-Book
Location
Online
Less detail

Enhanced Recovery After Surgery : A Complete Guide to Optimizing Outcomes

https://libcat.nshealth.ca/en/permalink/provcat45424
Olle Ljungqvist, Nader K. Francis, Richard D. Urman, editors. --Cham: Springer , c2020.
Available Online
View e-Book
Location
Online
This book is the first comprehensive, authoritative reference that provides a broad and comprehensive overview of Enhanced Recovery After Surgery (ERAS). Written by experts in the field, chapters analyze elements of care that are both generic and specific to various surgeries. It covers the patient journey through such a program, commencing with optimization of the patient’s condition, patient education, and conditioning of their expectations. Organized into nine parts, this book discusses meta…
Available Online
View e-Book
Other Authors
Ljungqvist, Olle
Francis, Nader K.
Urman, Richard D.
Responsibility
Olle Ljungqvist, Nader K. Francis, Richard D. Urman, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2020
Physical Description
1 online resource (xxiii, 654 p.) : 161 illus., 127 illus. in color
ISBN
9783030334437
9783030334420 (Print ed.)
9783030334444 (Print ed.)
9783030334451 (Print ed.)
Subjects (MeSH)
Enhanced Recovery After Surgery
Postoperative Care - methods
Postoperative Complications - prevention & control
Treatment Outcome
Specialty
General Surgery
Perioperative Medicine
Abstract
This book is the first comprehensive, authoritative reference that provides a broad and comprehensive overview of Enhanced Recovery After Surgery (ERAS). Written by experts in the field, chapters analyze elements of care that are both generic and specific to various surgeries. It covers the patient journey through such a program, commencing with optimization of the patient’s condition, patient education, and conditioning of their expectations. Organized into nine parts, this book discusses metabolic responses to surgery, anaesthetic contributions, and optimal fluid management after surgery. Chapters are supplemented with examples of ERAS pathways and practical tips on post-operative pain control, feeding, mobilization, and criteria for discharge. Enhanced Recovery After Surgery: A Complete Guide to Optimizing Outcomes is an indispensable manual that thoroughly explores common post-operative barriers and challenges.
Contents
Part I. Introduction -- 1. Enhanced Recovery After Surgery: A Paradigm Shift in Perioperative Care -- 2. Physiology and Pathophysiology of ERAS -- 3. Guidelines for Guidelines -- Part II. Preoperative Preparation -- 4. Preoperative Fasting and Carbohydrate Treatment -- 5. Preoperative Patient Education -- 6. Perioperative Optimization of Patient Nutritional Status -- 7. Anemia and Blood Management -- 8. Perioperative Smoking and Alcohol Cessation -- 9. Preoperative Medical Optimization -- 10. Prehabilitation -- 11. Cognitive Behavior Counseling – Preoperative Preparation in ERAS -- 12. Bowel Preparation: Always, Sometimes, Never? -- 13. Pharmacogenomics in Perioperative Care -- Part III. Intraoperative Management -- 14. Anesthetic Management and the Role of the Anesthesiologist in Reducing Surgical Stress and Improving Recovery -- 15. Analgesia During Surgery (Medications) -- 16. Regional Anesthesia Techniques for Abdominal Operations -- 17. Prevention of Intraoperative Hypothermia -- 18. Perioperative Intravenous Fluid Therapy in ERAS Pathways -- 19. ERAS and Minimally Invasive Surgical Techniques -- 20. Tubes and Drains: Current Updates on Evidence on Their Role Within Recovery -- Part IV. Postoperative Management -- 21. Management of Postoperative Nausea and Vomiting (PONV) -- 22. Early Oral Nutrition -- 23. Early Ambulation and Physiotherapy After Surgery -- 24. Postoperative Multimodal Pain Management -- 25. Nursing Considerations During Patient Recovery -- Part V. Prevention of Postoperative Complications -- 26. Long-Term Outcomes Related to ERAS -- 27. Postoperative Ileus: Prevention and Treatment -- 28. Antibiotic Prophylaxis and Surgical Site Infection Prevention -- 29. Thromboprophylaxis -- Part VI. ERAS After Discharge -- 30. Functional Recovery at Home and After Discharge -- 31. Recovery Within the Cancer Journey -- 32. Readmission Challenges and Impacts Within ERAS -- 33. An Example of a Patient’s Experience in ERAS -- Part VII. Safety and Quality Improvement in ERAS -- Measuring Outcomes in ERAS -- 35. Measurement of Recovery Within ERAS -- 36. Measuring Compliance: Audit and Data Collection -- 37. Success and Failure of ERAS: Prediction Models of Outcomes -- 38. Research Methods in Enhanced Recovery After Surgery -- 39. Toward a Learning System for ERAS: Embedding Implementation and Learning Evaluation -- Part VIII. Specialty-Specific Enhanced Recovery Programs -- 40. ERAS in Colorectal Surgery -- 41. Enhanced Recovery After Surgery: Recommendations for Esophagectomy -- 42. Enhanced Recovery After Gastrectomy -- 43. Bariatric Surgery -- 44. ERAS for Major Urological Procedures: Evidence Synthesis and Recommendations -- 45. ERAS for Breast Reconstruction -- 46. Gynecologic/Oncology Surgery -- 47. Enhanced Recovery After Surgery: Cesarean Delivery -- 48. ERAS in Spine Surgery -- 49. Orthopedic Surgery in Enhanced Recovery After Surgery -- 50. ERAS in Otolaryngology – Head and Neck Surgery -- 51. Cardiac Surgery ERAS -- 52. Vascular Surgery and ERAS -- 53. Thoracic Surgery -- 54. Enhanced Recovery Program in the Ambulatory Surgery Setting -- 55. Enhanced Recovery After Surgery: Emergency Laparotomy -- 56. Liver Surgery -- 57. Pancreatic Surgery -- 58. Pediatric Enhanced Recovery After Surgery -- Part IX. Administrative -- 59. Department-wide Implementation of an Enhanced Recovery Pathway: Barriers and Facilitators -- 60. Introducing Enhanced Recovery Programs into Practice: Lessons Learned from the ERAS® Society Implementation Program -- 61. Enhanced Recovery After Surgery – Making the Business Case: Economics – The Alberta Experience -- 62. ERAS® Society and Latin American -- 63. ERAS® Society and Asia -- 64. ERAS for Low- and Middle-Income Countries -- 65. ERAS Position in the Global Surgical Community.
Format
e-Book
Location
Online
Less detail

Enhancing Patient Engagement in Pulmonary Healthcare : The Art and Science

https://libcat.nshealth.ca/en/permalink/provcat45199
Marilyn L. Moy, Felicity Blackstock, Linda Nici, editors. --Cham: Humana Press , c2020.
Available Online
View e-Book
Location
Online
This book examines the most up-to-date strategies that can be used to enhance the healthcare professional-patient interaction to influence positive behavior change and improve treatment adherence in pulmonary healthcare. This book is written by experts in the field who couple their experience with practical strategies (the art) with evidence-based theory (the science). Chapters discuss global concepts such as motivational interviewing on improving engagement and how to apply strategies to speci…
Available Online
View e-Book
Other Authors
Moy, Marilyn L.
Blackstock, Felicity
Nici, Linda
Other Authors
American Thoracic Society
Responsibility
Marilyn L. Moy, Felicity Blackstock, Linda Nici, editors
Place of Publication
Cham
Publisher
Humana Press
Date of Publication
c2020
Physical Description
1 online resource (xi, 293 p.) : 60 illus., 47 illus. in color
Series Title
Respiratory medicine
ISBN
9783030448899
9783030448882 (Print ed.)
9783030448905 (Print ed.)
9783030448912 (Print ed.)
ISSN
2197-7372
Subjects (MeSH)
Patient Education as Topic
Patient Participation
Physician-Patient Relations
Respiratory Tract Diseases - therapy
Treatment Adherence and Compliance
Specialty
Health Education
Pulmonary Medicine
Abstract
This book examines the most up-to-date strategies that can be used to enhance the healthcare professional-patient interaction to influence positive behavior change and improve treatment adherence in pulmonary healthcare. This book is written by experts in the field who couple their experience with practical strategies (the art) with evidence-based theory (the science). Chapters discuss global concepts such as motivational interviewing on improving engagement and how to apply strategies to specific situations (for examples: smoking cessation, promoting physical activity, inhaler adherence, supplemental oxygen use, and non-invasive ventilation) commonly experienced on the front lines of caring for patients with pulmonary disorders. The textbook raises awareness of direct approaches and recent technological advances that healthcare professionals can use to support positive behavior change in their day-to-day clinical practice. Effective, patient-tailored self-management interventions are discussed, including the evidence for these interventions and ways to personalize the strategies to each patient’s unique needs. This book is an ideal guide for healthcare professionals working with patients experiencing chronic pulmonary conditions, including pulmonologists, primary care physicians, physician assistants, nurses, trainees, and the many allied health professionals involved in delivering care such as respiratory therapists, pharmacists, and behavioral psychologists. The concepts of this book can also be applied to the management of other chronic diseases such as coronary artery disease and diabetes mellitus.
Contents
1. Defining patient engagement, health behavior change, and disease self-management -- 2. Learning: developing knowledge through making meaning -- 3. Psychomotor skill development: learning what AND how to do -- 4. Best practice in educational design for patient learning -- 5. The impact of self-efficacy on behavior change: the roles of socio-cultural and mental health factors -- 6. Integrating motivational interviewing into pulmonary healthcare -- 7. Anxiety, depression, and using evidence-based techniques and strategies to support engagement and adherence -- 8. Technology to enhance engagement in physical activity -- 9. The role of mind-body approaches in promoting healthcare engagement and positive behavior change -- 10. Strategies to improve adherence to supplemental oxygen therapy -- 11. Self-management: personalized action plans for COPD exacerbations -- 12. Domiciliary noninvasive ventilation: strategies for improving adherence to home use -- 13. Teaching the practical skill of correct inhaler use: knowing and being able to do -- 14. Smoking cessation: breaking the strong addiction.
Format
e-Book
Location
Online
Less detail

Handbook of Cancer Survivorship

https://libcat.nshealth.ca/en/permalink/provcat42682
Michael Feuerstein, Larissa Nekhlyudov, editors. (Second edition) --Cham: Springer , c2018.
Available Online
View e-Book
Location
Online
The timely revision of this authoritative handbook gives a wide range of health care providers practical insights and strategies for treating cancer survivors' long-term physical and mental health issues and promoting healthy lifestyle habits. Details of new and emerging trends in research and practice enhance readers' awareness of issues faced by survivors so they may better detect, monitor, intervene in, and if possible prevent distressing conditions and potentially harmful outcomes. Of parti…
Available Online
View e-Book
Other Authors
Feuerstein, Michael
Nekhlyudov, Larissa
Responsibility
Michael Feuerstein, Larissa Nekhlyudov, editors
Edition
Second edition
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (xv, 419 p.) : 27 illus., 17 illus. in color
ISBN
9783319774329
9783319774305 (print ed.)
9783319774312 (print ed.)
Subjects (MeSH)
Cancer Survivors
Neoplasms - psychology
Neoplasms - rehabilitation
Quality of Life
Survivorship
Specialty
Medical Oncology
Abstract
The timely revision of this authoritative handbook gives a wide range of health care providers practical insights and strategies for treating cancer survivors' long-term physical and mental health issues and promoting healthy lifestyle habits. Details of new and emerging trends in research and practice enhance readers' awareness of issues faced by survivors so they may better detect, monitor, intervene in, and if possible prevent distressing conditions and potentially harmful outcomes. Of particular emphasis are different models of care that may be applicable to diverse clinical settings around the world. New or updated chapters cover major challenges to survivors' quality of life and options for health care delivery across key life domains, including: Adaptation and coping post-treatment. Problems of aging in survivorship, including disparities and financial hardship. Well-being concerns including physical activity, weight loss, nutrition, and smoking cessation. Core functional areas such as work, sleep, relationships, and cognition. Large-scale symptoms including pain, distress, and fatigue. Models of care including primary care and comprehensive cancer center. International perspectives PLUS, insights about lessons learned and challenges ahead. With survivorship and survivorship care becoming an ever more important part of the clinical landscape, the Second Edition of the Handbook of Cancer Survivorship is an essential reference for oncology specialists, primary care providers, mental health professionals, rehabilitation providers, as well as public health specialists, epidemiologists and policy makers.
Contents
Part I. Overview of Cancer Survivorship -- 1. Cancer Survivorship: A Bird’s Eye View from an Insider a Decade Later -- 2. Epidemiology -- 3. Adjustment to Life as a Cancer Survivor -- 4. Quality Care -- Part II. Unique Challenges -- 5. Disparities -- 6. Aging -- 7. Financial Hardship -- Part III. Problem Area: Symptoms -- 8. Fatigue -- 9. Distress -- 10. Pain -- Part IV. Problem Area: Function -- 11. Cognitive Dysfunction -- 12. Work -- 13. Sleep -- 14. Interpersonal Relationships -- Part V. Problem Area: Lifestyle -- 15. Physical Activity -- 16. Nutrition and Weight Management -- 17. Smoking -- Part VI. Health Care -- 18. Primary Care -- 19. Comprehensive Healthcare -- 20. International Perspectives -- Part VII. Future Directions -- 21. Lessons Learned and Challenges Ahead.
Format
e-Book
Location
Online
Less detail

How to use nicotine replacement therapy (NRT)

https://libcat.nshealth.ca/en/permalink/chpams35482
Nova Scotia Health Authority. Mental Health and Addictions, Nova Scotia Health Authority. Respiratory Therapy Services, Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Occupational Health Safety and Wellness. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2145
Available Online
View Pamphlet
Nova Scotia Health promotes a smoke-free, tobacco-free, and vape-free environment for patients, visitors, and staff. Nova Scotia Health is committed to helping people smoke less, stop smoking, and stay smoke-free. This pamphlet provides information about nicotine replacement therapy options such as the nicotine patch, nicotine gum, nicotine lozenges, and nicotine inhaler.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Mental Health and Addictions
Nova Scotia Health Authority. Respiratory Therapy Services
Nova Scotia Health Authority. Pharmacy Services
Nova Scotia Health Authority. Occupational Health Safety and Wellness
Alternate Title
How to use NRT
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Smoking Cessation
Tobacco Use Cessation Devices
Subjects (LCSH)
Smoking cessation
Smoking cessation products
Abstract
Nova Scotia Health promotes a smoke-free, tobacco-free, and vape-free environment for patients, visitors, and staff. Nova Scotia Health is committed to helping people smoke less, stop smoking, and stay smoke-free. This pamphlet provides information about nicotine replacement therapy options such as the nicotine patch, nicotine gum, nicotine lozenges, and nicotine inhaler.
Responsibility
Prepared by: Mental Health & Addictions, Respiratory Therapy, Pharmacy Services, Occupational Health Safety & Wellness
Pamphlet Number
2145
Less detail

Integrative Therapies in Lung Health and Sleep

https://libcat.nshealth.ca/en/permalink/provcat31015
Linda Chlan, Marshall I. Hertz, editors. --New York, NY: Humana Press , c2012.
Available Online
View e-Book
Location
Online
Integrative Therapies in Lung Health and Sleep provides an overview of integrative therapies to assist clinicians caring for patients with acute or chronic lung diseases and sleep disorders--emphasizing the scientific bases for these therapies; and their implementation into clinical practice. This volume focuses on complementary and alternative medicine (CAM) treatments, modalities, and practices that are integrated with conventional medical treatment and for which there is some evidence of saf…
Available Online
View e-Book
Other Authors
Chlan, Linda
Hertz, Marshall I
Responsibility
Linda Chlan, Marshall I. Hertz, editors
Place of Publication
New York, NY
Publisher
Humana Press
Date of Publication
c2012
Physical Description
1 online resource (xv, 327 p. : 62 ill., 4 ill. in color)
Series Title
Respiratory medicine (New York, N.Y.)
ISBN
9781617795794
Subjects (MeSH)
Complementary Therapies - methods
Integrative Medicine - methods
Lung Diseases - therapy
Sleep Wake Disorders - therapy
Subjects (LCSH)
Alternative medicine
Pneumology
Abstract
Integrative Therapies in Lung Health and Sleep provides an overview of integrative therapies to assist clinicians caring for patients with acute or chronic lung diseases and sleep disorders--emphasizing the scientific bases for these therapies; and their implementation into clinical practice. This volume focuses on complementary and alternative medicine (CAM) treatments, modalities, and practices that are integrated with conventional medical treatment and for which there is some evidence of safety and efficacy. Whole Medical Systems, with a specific focus on Traditional Chinese Medicine, are also addressed. Individual chapters are devoted to specific health conditions or illnesses, addressing the current state of the science in the four organizing CAM domains, including available information regarding benefits, risks, or safety considerations. Unique aspects of this volume are the chapters related to evaluation of the evidence base for integrative therapies; new animal model research with herbal preparations focused on the serious problem of sepsis in the ICU; guidance for counseling patients with chronic lung illnesses who may be desperate for a cure; and palliative and end-of-life care for patients with chronic lung conditions. Clinicians in various health care settings will find Integrative Therapies in Lung Health and Sleep beneficial in their practice, particularly as the use of integrative therapies becomes more widespread.
Contents
Overview of integrative therapies and healing practices -- Evaluation of integrative therapies for research and practice -- Integrative therapies in chronic pulmonary conditions -- Integrative therapies for people with asthma -- Integrative therapies for people with asthma -- Integrative therapies for people with chronic obstructive pulmonary disease -- Integrative therapies for people with interstitial lung disease, idiopathic pulmonary fibrosis, and pulmonary arterial hypertension -- Integrative therapies for people with cystic fibrosis -- Integrative therapies for people with lung cancer -- Integrative therapies for lung transplantation recipients -- Integrative therapies in critical care and sleep disorders -- Integrative therapies in the management of critically ill patients -- Integrative therapies to promote sleep in the intensive care unit -- Future application of integrative therapies for sepsis : bench and experimental animal models -- Integrative therapies to manage acute and chronic sleep disorders -- Integrative therapies to promote lung health -- Integrative therapies for tobacco cessation -- Integrative therapies to support palliative and end-of-life care in lung disease -- Whole medical systems in lung health and sleep : focus on traditional Chinese medicine -- Counseling patients with chronic lung disease : interdisciplinary strategies for reducing distress.
Format
e-Book
Location
Online
Less detail

40 records – page 1 of 2.